Characteristics of AIH patients assayed by PhIP-seq (n = 115)
| | Mean ALT | Mean AST | Mean IgG | Advanced fibrosis (F3/F4) | Steroid-containing regimen | Nonsteroid regimen | No reported treatmenta | Anti-SMA positive |
|---|---|---|---|---|---|---|---|---|
| AIH | 79 | 66 | 1,520 | 58% | 46% | 34% | 20% | 81% |
| | Mean ALT | Mean AST | Mean IgG | Advanced fibrosis (F3/F4) | Steroid-containing regimen | Nonsteroid regimen | No reported treatment | Anti-SMA positive |
|---|---|---|---|---|---|---|---|---|
| AIH | 79 | 66 | 1,520 | 58% | 46% | 34% | 20% | 81% |
Anti-SMA, anti-smooth muscle antibodies.
6% of patients were reported as being off all treatment, and an additional 14% of patients did not have a treatment regimen reported.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.